Ning-Hung Chen Selected Research

Dyspnea (Shortness of Breath)

1/2022	Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study.
1/2016	Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ning-Hung Chen Research Topics

Disease

26	Obstructive Sleep Apnea 10/2021 - 04/2003
10	Snoring 01/2019 - 06/2006
9	Hypoxia (Hypoxemia) 01/2022 - 01/2014
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2015
6	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 09/2002
6	Disorders of Excessive Somnolence (Hypersomnia) 08/2021 - 04/2003
6	Acute Lung Injury 04/2020 - 09/2015
5	Apnea 01/2022 - 04/2003
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2017 - 10/2008
4	Nasal Obstruction 08/2021 - 02/2008
3	Sepsis (Septicemia) 04/2020 - 01/2018
3	Ventilator-Induced Lung Injury 04/2020 - 09/2015
2	Dyspnea (Shortness of Breath) 01/2022 - 01/2016
2	Hypertension (High Blood Pressure) 01/2021 - 07/2011
2	Body Weight (Weight, Body) 06/2020 - 12/2015
2	Endotoxemia 04/2020 - 01/2018
2	Neoplasms (Cancer) 03/2020 - 01/2020
2	Atherosclerosis 12/2019 - 03/2016
2	Infections 03/2019 - 01/2015
2	Albuminuria 01/2019 - 06/2016
2	Atrophy 01/2018 - 01/2016
2	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018 - 01/2015
2	Pneumonia (Pneumonitis) 11/2017 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 04/2011
2	Hyperoxia 01/2016 - 09/2015
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2007 - 09/2004
1	Heart Failure 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Stroke (Strokes) 01/2022
1	Cheyne-Stokes Respiration 01/2022
1	Cognitive Dysfunction 01/2022
1	Tonsillitis 05/2021
1	Hypercholesterolemia 01/2021
1	Obesity 06/2020
1	Lung Injury 04/2020
1	Muscular Atrophy (Muscle Atrophy) 03/2019
1	Tuberculosis (Tuberculoses) 03/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 12/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2017
1	Fibrosis (Cirrhosis) 11/2017
1	Idiopathic Pulmonary Fibrosis 11/2017
1	Chronic Renal Insufficiency 03/2017

Drug/Important Bio-Agent (IBA)

5	GoldIBA 01/2021 - 01/2015
4	Oxygen (Dioxygen)IBA 01/2022 - 11/2012
4	Messenger RNA (mRNA)IBA 10/2021 - 09/2015
4	Pharmaceutical PreparationsIBA 10/2020 - 09/2004
4	C-Reactive ProteinIBA 01/2016 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 01/2020
2	Muscarinic AntagonistsIBA 01/2022 - 01/2021
2	Free RadicalsIBA 04/2020 - 01/2018
2	CytokinesIBA 04/2020 - 09/2015
2	CC ChemokinesIBA 12/2019 - 01/2014
2	Caspase 3 (Caspase-3)IBA 01/2018 - 01/2016
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2018 - 01/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2017 - 01/2017
2	CreatinineIBA 06/2016 - 07/2011
2	AlbuminsIBA 06/2016 - 07/2011
2	p38 Mitogen-Activated Protein KinasesIBA 03/2016 - 01/2014
2	Malondialdehyde (Propanedial)IBA 01/2016 - 09/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 01/2015
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022
1	vilanterolIBA 01/2022
1	GSK573719IBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022
1	tiotropium-olodaterolIBA 01/2022
1	indacaterolIBA 01/2022
1	ChemokinesIBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	SteroidsIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 04/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2020
1	Chemokine CCL5IBA 12/2019
1	AerosolsIBA 03/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	Cystatin CIBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	ethyl pyruvateIBA 01/2019
1	Toll-Like Receptor 4IBA 01/2018
1	Muscle Proteins (Muscle Protein)IBA 01/2018
1	EndotoxinsIBA 01/2018
1	nintedanibIBA 11/2017
1	Tyrosine Kinase InhibitorsIBA 11/2017
1	theasinensin AIBA 01/2017
1	trichostatin A (A 300)IBA 01/2017

Therapy/Procedure

11	Therapeutics 01/2022 - 02/2004
10	Artificial Respiration (Mechanical Ventilation) 01/2022 - 09/2015
9	Continuous Positive Airway Pressure 01/2022 - 04/2003
3	Mechanical Ventilators (Ventilator) 01/2018 - 12/2015
3	Nasal Surgical Procedures 11/2009 - 02/2008
1	Duration of Therapy 08/2021
1	Bariatric Surgery 06/2020
1	Renal Dialysis (Hemodialysis) 03/2017
1	Orthognathic Surgery 01/2017